Evidence map›Paper›PMID 36138475›Full record

ArticleBMC medicine2022

High prevalence and significant ethnic differences in actionable HbA

Archana Sharma, Ingrid Nermoen, Elisabeth Qvigstad, Anh T Tran, Christine Sommer, Naveed Sattar, Jason M R Gill, Hanne L Gulseth, Stina T Sollid, Kåre I Birkeland

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in BMC medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.1field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 2 countries.

Archana SharmaDepartment of Endocrinology, Akershus University Hospital, University of Oslo, 1478, Lørenskog, Norway. archana.sharma@ahus.no.ORCID 0000-0002-3188-6647
Ingrid NermoenDepartment of Endocrinology, Akershus University Hospital, University of Oslo, 1478, Lørenskog, Norway.
Elisabeth QvigstadInstitute of Clinical Medicine, University of Oslo, Oslo, Norway.
Anh T TranInstitute of Health and Society, Department of General Practice, University of Oslo, Oslo, Norway.
Christine SommerInstitute of Clinical Medicine, University of Oslo, Oslo, Norway.
Naveed SattarInstitute of Cardiovascular and Medical Sciences, University of Glasgow, BHF Glasgow Cardiovascular Research Centre, 126 University Place, Glasgow, G12 8TA, UK.
Jason M R GillInstitute of Cardiovascular and Medical Sciences, University of Glasgow, BHF Glasgow Cardiovascular Research Centre, 126 University Place, Glasgow, G12 8TA, UK.
Hanne L GulsethNorwegian Institute of Public Health, Oslo, Norway.
Stina T SollidDepartment of Medicine, Drammen Hospital, Vestre Viken Health Trust, Drammen, Norway.
Kåre I BirkelandInstitute of Clinical Medicine, University of Oslo, Oslo, Norway.
Oslo University Hospital · NOUniversity of Oslo · NOUniversity of Glasgow · GBDrammen Hospital · NONorwegian Institute of Public Health · NO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe type 2 diabetes risk after gestational diabetes mellitus (GDM) is twice as high in South Asian compared to European women. Current guidelines differ regarding which test to use as a screening-tool post-GDM. We aimed to identify ethnic differences in the prevalence rates and early predictors for actionable HbA

methodsThis cross-sectional study, enrolling South Asian and Nordic women 1-3 years after a diagnosis of GDM, was undertaken at three hospitals in Norway. We performed a clinical and laboratory evaluation including an oral glucose tolerance test (OGTT). Medical records were used to retrieve data during pregnancy. Prediabetes was classified with HbA

resultsWe included 163 South Asian and 108 Nordic women. Actionable HbA

conclusionsIn women with GDM 1-3 year previously, we found high prevalence and significant ethnic differences in actionable ADA-HbA

Indexed as

Diabetes, GestationalDiabetes Mellitus, Type 2Prediabetic StateBlood GlucoseCross-Sectional StudiesFemaleHumansPregnancyPrevalenceBlood GlucoseEthnic groupsGestational diabetes mellitusGlucose metabolism disordersGlycated haemoglobinOverweightPrevention

Identifiers

PMID36138475
PMCPMC9502889
OpenAlexW4296794091

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.